Treatment of the first HIV positive patient in ABIVAX’s Phase IIa clinical trial with ABX464
2 February 2015 | By ABIVAX
ABIVAX today announced that enrollment has been initiated and the first HIV positive patient dosed in a Phase IIa clinical trial of ABX464...